SEARCH

SEARCH BY CITATION

Keywords:

  • Colitis;
  • FoxP3;
  • IL-21;
  • TGF-β;
  • Treg cells

Abstract

  1. Top of page
  2. Abstract
  3. Introduction
  4. Results
  5. Discussion
  6. Material and methods
  7. Acknowledgements

Regulatory T (Treg) cells play a key role in the maintenance of the immune system homeostasis. Treg cells can be generated in the periphery under control of TGF-β, a cytokine involved in the negative control of the immune system. However, TGF-β cooperates with IL-6 in the generation of Th17 cells, a novel class of effector cells involved in numerous inflammatory diseases, including colitis. Therefore, TGF-β emerges as a mediator of both anti-inflammatory and pro-inflammatory processes, depending on the local cytokine milieu. Here we demonstrate that IL-21, a type-1 cytokine produced by T cells and involved in the pathogenesis of immune-mediated diseases, prevents the TGF-β-dependent expression of FoxP3, the master regulator of Treg cell commitment, and the induction of suppressive capacity in naive CD4+ T cells, while promoting the differentiation of Th17 cells. In vivo, CD4+ naive T cells activated in the presence of TGF-β and IL-21 failed to suppress colitis while inducing an inflammatory response characterized by high levels of IL-17 and RORγt, the transcription factor expressed by Th17 cells. Therefore, IL-21 emerges as a key modulator of TGF-β signaling, leading to the reciprocal differentiation of Treg and Th17 cells.

Abbreviation:
Ti-Treg cell:

TGF-β-induced regulatory T cell

Introduction

  1. Top of page
  2. Abstract
  3. Introduction
  4. Results
  5. Discussion
  6. Material and methods
  7. Acknowledgements

Maintenance of immune homeostasis depends on the tightly controlled balance between activating and suppressing molecular events. Thus, defective counter-regulation and/or excessive activation of effector cells may each promote tissue-damaging immune responses 13.

Interleukin (IL)-21 is a T cell-derived cytokine that signals through a receptor composed of a specific subunit, termed IL-21R, and the common γ-chain subunit, shared with IL-2, IL-4, IL-7, IL-9, IL-13, and IL-15 receptors. IL-21R is highly expressed on T and B lymphocytes and NK cells, all of which functionally respond to IL-21 4. Previous studies have shown that IL-21 is important in the regulation of immunoglobulin synthesis by plasma cells, cytotoxic activity of NK and CD8+ T cells, and cytokine production by CD4+ T cells. Enhanced expression of IL-21 and/or IL-21R has been documented in various diseases associated with a defective capacity of counter-regulatory mechanisms to dampen T cell-mediated inflammatory responses 5, 6. IL-21 also appears to positively regulate the homeostatic expansion of autoreactive T cells in murine models of diabetes 2. Overall, these findings suggest that IL-21 may play an important role in the induction and/or perpetuation of T cell-dependent inflammatory processes.

CD4+CD25+ regulatory T (Treg) cells are a specialized class of lymphocytes characterized by the expression of the forkhead transcription factor FoxP3, the master regulator of the regulatory cell commitment 7. Naturally occurring Treg cells are produced by the thymus, but Treg cells can also be induced in the periphery by TGF-β-mediated conversion of CD4+CD25 T cells into FoxP3-positive CD4+CD25+ T cells (now termed Ti-Treg cells) 8, 9. Functionally, Treg cells can suppress T cell activation and proliferation in vitro and in vivo10. A reduced number and/or activity of Treg cells is associated with the development and/or progression of various inflammatory diseases 7. Recent evidence has also suggested that inflammatory stimuli can suppress either the generation or activity of Ti-Treg cells 11, 12. Here, we demonstrate that the pro-inflammatory cytokine IL-21 acts as an important immunomodulator by preventing the peripheral generation of Ti-Treg cells and promoting the differentiation of Th17 cells, a novel class of effector T cells characterized by the expression of the transcription factor RORγt and secretion of IL-17, IL-6 and TNF-α. We also demonstrate that Ti-Treg cells generated in the presence of IL-21 fail to suppress colitis in a murine adoptive transfer model while promoting an immune response characterized by high levels of IL-17.

Results

  1. Top of page
  2. Abstract
  3. Introduction
  4. Results
  5. Discussion
  6. Material and methods
  7. Acknowledgements

IL-21 suppresses TGF-β-mediated induction of FoxP3 in CD4+CD25 cells

We and others have previously demonstrated that polyclonally activated CD4+CD25 T cells differentiate into FoxP3-expressing cells in the presence of TGF-β 8, 9. To assess whether IL-21 may interfere with this process, CD4+CD25 T cells were sorted from BALB/c splenocytes and polyclonally activated in the presence of TGF-β with or without recombinant IL-21. As expected, TGF-β markedly enhanced FoxP3 expression, and no change in FoxP3 RNA expression was seen in cells activated in the presence of IL-21 alone. In contrast, IL-21 dose-dependently reduced the TGF-β-mediated FoxP3 induction (Fig. 1A, B). A marked reduction in the percentage of FoxP3-positive cells was also seen in IL-21-treated Ti-Treg cell cultures (Fig. 1C).

thumbnail image

Figure 1. IL-21 suppresses TGF-β-mediated FoxP3 induction in CD4+CD25 T cells. (A) BALB/c CD4+CD25 T cells were activated with anti-CD3 Ab, anti-CD28 Ab, and TGF-β with or without IL-21 (100 ng/mL). After 5 days of culture, FoxP3 RNA was evaluated by real-time PCR. (B) Experiments were performed as indicated in (A), and IL-21 was used at the indicated concentrations. Data indicate means ± SD of triplicates of a single assay and are representative of three separate experiments. (C, D) CD4+CD25 T cells activated in the presence of anti-CD3 and anti-CD28 Ab (C) or soluble anti-CD3 Ab and APC (D). Cell cultures were either left untreated (medium) or treated with TGF-β in the presence or absence of IL-21. After 5 days of culture, FoxP3-positive cells were evaluated by flow cytometry. Numbers above lines indicate the percentages of FoxP3-expressing cells. One of three representative experiments is shown. (E) IL-21 does not reverse the TGF-β-mediated suppression of TNF-α, IL-6, and IFN-γ secretion by CD4+CD25 T cells activated with anti-CD3 and anti-CD28 Ab. Data are means ± SD of three separate experiments, and indicate the values of cytokines (pg/mL) measured in 5-day culture supernatants (* p <0.05).

Download figure to PowerPoint

IL-21 is known to negatively modulate the in vitro activation of antigen-presenting cells (APC) 13, so we next investigated whether IL-21 could suppress FoxP3 expression in a more physiologic setting, where Ti-Treg cells were generated in the presence of APC with or without IL-21. The results in Fig. 1D show that IL-21 was also able to block the induction of Ti-Treg cells in this experimental setting.

We then examined whether IL-21 reverses the inhibitory effect of TGF-β on T cell cytokine production. CD4+CD25 T cells were activated in the presence or absence of TGF-β with or without IL-21. As expected, TGF-β significantly inhibited the secretion of TNF-α, IL-6, and IFN-γ, but this was not counteracted by IL-21. Moreover, in the same cell cultures, the ability of TGF-β to inhibit the expression of CD45RB and CD69 was not altered by IL-21 (not shown). The increase in membrane CD44 and CD62L on T cells in TGF-β-treated cultures was also not affected by IL-21 (not shown). Overall, these findings indicate that IL-21 selectively inhibits the TGF-β-mediated induction of FoxP3, rather than blocking the activity of this cytokine.

At what stage does IL-21 inhibit Treg cell induction?

IL-21 is a growth factor for CD4+ effector T cells. Therefore, it was possible that the reduced expression of FoxP3 in IL-21-treated cultures of CD4+CD25 T cells activated with anti-CD3 Ab, anti-CD28 Ab, and TGF-β was because of preferential expansion of FoxP3-negative T cells. We first examined FoxP3 in cultures of CD4+CD25 T cells activated in the presence or absence of IL-21 for different times. As shown in Fig. 2A, the inhibition of FoxP3 RNA in IL-21-treated cultures occurred early (i.e. 12 and 24 h) and persisted. Second, we evaluated whether IL-21 exerts its effects in already established cultures of CD4+CD25 T cells activated with anti-CD3 Ab, anti-CD28 Ab and TGF-β. IL-21 was added 0, 12, and 48 h after the anti-CD3 + CD28 Ab activation of T cells in the presence of TGF-β. Importantly, IL-21 caused a reduction of FoxP3 RNA when added simultaneously with TGF-β as well as 12 and 48 h after the cell activation (Fig. 2B). These effects were paralleled by a reduction in the percentage of FoxP3-positive cells even when IL-21 was added 48 h after the activation of cells in the presence of TGF-β (Fig. 2C). Finally, we examined whether IL-21 differently modulated the proliferation of FoxP3-positive and -negative T cells. Freshly isolated CD4+CD25 T cells were stained with CFSE and activated in the presence of TGF-β, with or without IL-21. After 5 days, cells were stained for FoxP3 and the number of divisions was evaluated in both the FoxP3-positive and FoxP3-negative T cell fractions. While the proliferating fraction of FoxP3-positive cells was slightly enhanced by IL-21, there was a marked proliferation (more than twofold) of FoxP3-negative cells in response to IL-21 (Fig. 3A, B). Overall, these data suggest that the relative reduction of the fraction of FoxP3-expressing cells in cultures added with IL-21 (Fig. 3A, B) is due to both the suppression of FoxP3 gene transcription and the preferential expansion of FoxP3-negative T cells.

thumbnail image

Figure 2. (A) Inhibition of FoxP3 RNA expression by IL-21 occurs at early and late time points. CD4+CD25 T cells were either left unstimulated (unst) or stimulated with anti-CD3 Ab, anti-CD28 Ab, and TGF-β, with (light gray) or without (dark gray) IL-21, and FoxP3 RNA was then evaluated at the indicated time points by real-time PCR. Levels were normalized to β-actin. A significant reduction in FoxP3 expression was seen in cultures to which IL-21 was added, and this was evident at all times. Data indicate means ± SD of triplicates of a single assay and are representative of three experiments in which similar results were obtained. (B) IL-21 inhibits FoxP3 induction in established cultures of Ti-Treg cells. CD4+CD25 T cells were activated with anti-CD3 Ab, anti-CD28 Ab, and TGF-β. IL-21 was added to the cultures at the same time as TGF-β, or 12 and 48 h later. Data indicate means ± SD of triplicates of a single assay and are representative of three independent experiments in which similar results were obtained. (C) Representative histogram of FoxP3-expressing cells in cultures of CD4+CD25 T cells activated with anti-CD3 Ab, anti-CD28 Ab, and TGF-β, in the presence or absence of IL-21, added at the same time as TGF-β or 48 h later. One of three representative experiments is shown.

Download figure to PowerPoint

thumbnail image

Figure 3. (A) IL-21 increases proliferation of FoxP3-negative cells. CFSE-labeled CD4+CD25 T cells were stimulated with anti-CD3, anti-CD28 Ab in the presence of TGF-β with or without IL-21. After 5 days, cells were stained with a FoxP3-specific antibody and proliferation of the FoxP3-positive and -negative cells was evaluated by flow cytometry. Numbers above lines indicate the percentages of proliferating cells. (B) Proliferation of FoxP3-positive and -negative cells activated in the presence of TGF-β and IL-21 relative to the proliferation in the presence of TGF-β alone. One of four representative experiments is shown.

Download figure to PowerPoint

IL-21 modulates the apoptosis of different cell types 14, 15 and promotes the survival of T cells by activating the phosphatidylinositol 3-kinase pathway 16. However, when IL-21 was added to CD4+CD25 T cells activated in the presence of TGF-β, no significant change in the rate of T cell apoptosis was seen both at 24 and 48 h (not shown).

IL-21 prevents the TGF-β-dependent induction of functional Treg cells

CD4+CD25 cells pre-activated in the presence of TGF-β with or without IL-21 were used in a conventional co-culture assay, and their capacity to suppress the proliferation of freshly isolated CFSE-labeled CD4+CD25 T (responder) cells was evaluated. Ti-Treg cells and naturally occurring Treg cells (CD4+CD25+) were able to suppress responder cell proliferation at all the responder/suppressor ratios. By contrast, T cells generated in the presence of TGF-β and IL-21 failed to exert any suppressive effect on the growth of responder cells (Fig. 4A). The analysis of the proliferation index in the different co-cultures showed a significant loss of the suppressive capacity of T cells generated in the presence of TGF-β and IL-21, in comparison to both Ti-Treg cells generated in the absence of IL-21 and naturally occurring CD4+CD25+ Treg cells (Fig. 4B). These data indicate that the IL-21-mediated suppression of the TGF-β-dependent induction of FoxP3 in CD4+CD25 T cells parallels the loss of their suppressive function in vitro.

thumbnail image

Figure 4. (A) Representative histograms of CFSE-labeled CD4+CD25 T cells (R = responders) (2 × 105 cells/well) cultured in the presence or absence of various concentrations of unlabeled (S = suppressors) CD4+CD25+ T cells, Ti-Treg cells, or CD4+CD25 cells pre-activated in the presence of TGF-β and IL-21 (TGF-β + IL-21/CD4+CD25). Numbers above lines indicate the percentage of non-proliferating cells after 3 days of culture. T cells generated in the presence of TGF-β and IL-21 showed a minimal suppressive capacity at all the R/S ratios when compared to both CD4+CD25+ T cells and Ti-Treg cells generated in the absence of IL-21. One of three representative experiments is shown. (B) The proliferation index of these three independent experiments was calculated and the average of the proliferation indexes ± standard error of the mean (SEM) are indicated (* p <0.05).

Download figure to PowerPoint

CD4+CD25 T cells treated with TGF-β and IL-21 fail to suppress colitis

We have previously demonstrated that in vitro generated Ti-Treg cells can prevent colitis in immunodeficient mice reconstituted with naive CD4+ T cells 10. In order to assess the in vivo effect of CD4+CD25 T cells activated in the presence of TGF-β and IL-21, SCID mice were reconstituted with freshly isolated CD4+CD25 T cells alone or together with an equal number of Ti-Treg cells or CD4+CD25 T cells pre-activated in the presence of TGF-β and IL-21. Mice reconstituted with CD4+CD25 T cells alone showed a progressive weight loss by day 10, and this weight loss was prevented by simultaneous transfer of Ti-Treg cells. When CD4+CD25 T cells were co-transferred with T cells generated in the presence of TGF-β and IL-21, no prevention of weight loss was seen (Fig. 5A). Endoscopy performed 3 wk after the reconstitution revealed signs of mild colitis in animals receiving CD4+CD25 T cells alone, which were completely suppressed by co-transfer of Ti-Treg cells. In contrast, mice reconstituted with CD4+CD25 T cells generated in the presence of TGF-β and IL-21 showed macroscopic signs of frank colitis as indicated by the presence of loose stools, loss of bowel wall translucency, and friable mucosa (Fig. 5B). Histology of the colons collected at day 25 after reconstitution showed a strong mucosal hypertrophy with loss of goblet cells, and enhanced infiltration of the mucosa with mononuclear cells in both mice receiving CD4+CD25 T cells alone or in combination with T cells generated in the presence of TGF-β and IL-21 (Fig. 5C). Analysis of cytokine RNA expression revealed that IFN-γ, TNF-α, IL-21 and IL-17 were significantly increased in the colon of mice receiving CD4+CD25 T cells pre-activated in the presence of TGF-β and IL-21 in comparison to those reconstituted with either CD4+CD25 T cells alone or with the addition of Ti-Treg cells (Fig. 5D). Animals receiving T cells generated in the presence of TGF-β and IL-21 showed reduced colonic (Fig. 5D), spleen and MLN (Fig. 5E) FoxP3 expression as compared with mice receiving Ti-Treg cells. Such a reduction of FoxP3 expression was associated with an increase of RORγt expression in the colonic mucosa (Fig. 5D), thus suggesting the accumulation of Th17-like cells at this level in animals receiving T cells generated in the presence of TGF-β and IL-21.

thumbnail image

Figure 5. CD4+CD25 T cells treated with TGF-β and IL-21 fail to suppress experimental colitis. (A) SCID mice were transferred with CD4+CD25 T cells alone, or with either Ti-Treg cells or CD4+CD25 T cells pre-activated in the presence of TGF-β and IL-21 (now indicated as TGF-β + IL-21/CD4+CD25). Mice receiving PBS were used as controls. The weight of each mouse was recorded daily. Each point represents the cumulative mean weight data of one experiment in which five mice per group were analyzed. Bars represent SEM. (B) Representative endoscopic pictures of mice belonging to different groups of mice 3 wk after the initial transfer. (C) Representative H&E-stained sections of colons collected from the different groups at the end of the experiment; 20× original magnification. (D) FoxP3, RORγt and cytokine expression were evaluated by real-time PCR in colonic specimens. FoxP3 expression was normalized on CD3 expression. Columns and error bars indicate average expression ± SD of five different mice (ns, not significant; * p <0.01, between mice receiving Ti-Treg cells and TGF-β + IL-21/CD4+CD25 T cells; ** p <0.01, between mice receiving CD4+CD25 T cells alone and TGF-β + IL-21/CD4+CD25 T cells). (E) FoxP3 expression in MLN and spleens as assessed by flow cytometry. Spleens and MLN were pooled from five different animals. Percentages of the different populations are indicated in the plot quadrants.

Download figure to PowerPoint

IL-21 autocrine secretion regulates the Ti-Treg and Th17 cell balance

Since mice receiving CD4+CD25 T cells pre-activated in the presence of IL-21 showed high expression of markers associated with Th17 cells, we investigated whether IL-21, in the presence of TGF-β, is able to redirect the genetic program leading to the generation of regulatory cells towards a Th17 phenotype. Indeed, activation of T cells in the presence of TGF-β and IL-21 resulted in a marked increase in the expression of IL-17 and RORγt as compared with cells activated in the presence of TGF-β alone (Fig. 6A). These data indicate that IL-21 acts as a switch between the genetic programs leading either to the generation of Ti-Treg or Th17 cells.

thumbnail image

Figure 6. Inhibition of FoxP3 RNA expression in CD4+CD25 T cells treated with IL-21 is associated with enhanced expression of IL-17 and the transcription factor RORγt. (A) CD4+CD25 T cells were activated with anti-CD3 Ab, anti-CD28 Ab, and TGF-β with or without IL-21 (100 ng/mL). After 5 days of culture, RNA transcripts for IL-17 and RORγt were evaluated by real-time PCR, and levels were normalized to β-actin. (B) Endogenous IL-21 is required for an optimal FoxP3 suppression and RORγt induction. CD4+CD25 cells isolated from IL-21 knockout mice (light gray) or wild-type littermates (dark gray) were activated in the presence or absence of TGF-β with IL-21 at different concentrations as indicated. FoxP3 and IL-21 expression were analyzed by real-time PCR. (C) RORγt expression in CD4+CD25 cells from wild-type and IL-21 knockout mice activated in the presence of TGF-β and IL-21 for 5 days. Data indicate means ± SD of triplicates of a single assay and are representative of three independent experiments in which similar results were obtained.

Download figure to PowerPoint

To further investigate the role of IL-21 in the generation of Ti-Treg cells, we first analyzed the induction of Ti-Treg cells in CD4+CD25 cells isolated either from IL-21 knockout mice and wild-type littermates. As shown in Fig. 6B (left panel), FoxP3 expression did not differ in IL-21–/– and wild-type T cells activated for 5 days in the presence of TGF-β alone, indicating that the endogenous expression of IL-21 is not sufficient to counteract the induction of Ti-Treg cells. This could rely on the fact that TGF-β inhibits the expression of endogenous IL-21 in T cells. Indeed the expression of IL-21 induced by activation of wild-type T cells was inhibited by the addition TGF-β to the culture medium (Fig. 6B, right panel). However, in the presence of limiting doses of exogenous IL-21, FoxP3 suppression was more profound in wild-type than in IL-21–/– cells (Fig. 6B, left panel), and this effect was associated with a dose-dependent recovery of the capacity to express endogenous IL-21 by wild-type cells (Fig. 6B, right panel). These data indicate that exogenous IL-21 induces its own expression in TGF-β-stimulated cells, which substantially contributes to the suppression of Ti-Treg cell induction. According to the essential role of endogenous IL-21 in the generation of Th17 cells, IL-21–/– cells expressed less RORγt when stimulated with TGF-β and exogenous IL-21 (Fig. 6C). Collectively, these data indicate that the induction of the autocrine expression of IL-21 plays an important role in the suppression of Treg cell induction and the generation of Th17 cells.

Discussion

  1. Top of page
  2. Abstract
  3. Introduction
  4. Results
  5. Discussion
  6. Material and methods
  7. Acknowledgements

TGF-β is an important immunosuppressive cytokine, as substantiated by the demonstration that TGF-β-deficient animals develop a multi-organ autoimmune disease leading to death shortly upon birth 17. The counter-regulatory properties of TGF-β are dependent both on a direct suppression of immune cell activation and the induction of Treg cells. We and others have previously demonstrated that TGF-β is able to promote the differentiation of naive T cells into regulatory cells in the periphery (Ti-Treg cells) 8, 9. However, in the presence of pro-inflammatory cytokines such as IL-6, TGF-β favors the differentiation of a novel class of CD4+ effector T cells 18, 19. These cells, termed Th17 cells, are characterized by the expression of the transcription factor RORγt and production of high levels of IL-17, and they have been implicated in the pathogenesis of several immune diseases, including colitis. In this study we investigated the effect of IL-21, a CD4+ T cell-derived cytokine produced in excess in chronic immune-inflammatory diseases on the induction of Ti-Treg cells. We show that IL-21 is able to prevent the induction of Ti-Treg cells as evidenced by the reduced expression of the transcription factor FoxP3. However, in the presence of IL-21, there was an enhanced proliferation of FoxP3-negative cells; it is therefore plausible that the reduced expression of FoxP3 in these cell cultures is imputable to a preferential expansion of FoxP3-negative cells. However, a reduced induction of FoxP3 was seen at early time points (i.e. 12 h) of culture, raising the possibility that IL-21 may directly inhibit FoxP3 gene transcription. A further possibility is that IL-21 might reduce the number of FoxP3-positive cells by promoting the transdifferentiation of Treg cells into Th17 cells 17.

Functionally, CD4+CD25 T cells pre-activated in the presence of TGF-β and IL-21 failed to suppress the proliferation of target T cells in vitro, thus confirming that suppression of FoxP3 correlates with the loss of Ti-Treg cell-suppressive capacity. Consistently, colitis induced by the adoptive transfer of CD4+CD25 cells in SCID mice was suppressed by Ti-Treg cells generated in the absence of IL-21, but not by T cells generated in the presence of TGF-β and IL-21. By contrast, these later cell types caused an even more severe colitis than that observed in recipients that received no Ti-Treg cells. Such colitis was characterized by a reduced number of FoxP3-expressing cells in the gut mucosa as well as in the spleen and MLN, indicating that IL-21-induced FoxP3 suppression is not transient but persists once cells are transferred in vivo. Moreover, mice receiving T cells generated in the presence of TGF-β and IL-21 exhibited high levels of IL-17 and RORγt in the colon. This is consistent with the recent observation that IL-21 in the presence of TGF-β induces Th17 cells 20, 21. Indeed, in our cell cultures, IL-21-mediated suppression of FoxP3 was accompanied by an increase of both IL-17 and RORγt, indicating that IL-21 can induce Th17 cells in the presence of TGF-β and suppresses the generation of Ti-Treg cells.

Finally, we demonstrate that endogenous IL-21 is required to obtain an optimal IL-21-mediated Ti-Treg cell suppression and Th17 cell induction. Indeed, we observed that exogenous IL-21 re-establishes the expression of IL-21 in TGF-β-stimulated cells. Moreover, analysis of IL-21–/– and wild-type T cells showed that endogenous IL-21 substantially contributes to the suppression of FoxP3 and the generation of Th17 cells. These data indicate that IL-21 generates a self-sustaining autocrine loop in the TGF-β stimulated T cells which play a key role in the balance between Ti-Treg and Th17 cell generation.

In summary, IL-21 emerges as a key cytokine for the maintenance of the mucosal immune system homeostasis by fine-tuning either the generation of tolerogenic Ti-Treg cells or that of pro-inflammatory Th17 cells. Our data also well fit with previous studies showing the ability of IL-21 to counteract the activity of Treg cells in other cell systems, and with the demonstration that IL-21 is up-regulated in diseases characterized by defects of counter-regulatory mechanisms. Moreover, there is evidence that blockade of IL-21 is useful to limit the severity of inflammation in experimental models of immune-mediated diseases, which may be due, at least in part, to an enhanced de novo generation of Ti-Treg cells 22, 23. In the context of gut disease, which we have used here to show the in vivo significance of IL-21 inhibition of Treg cell development and function, our results reinforce a new notion which is that the host deliberately inhibits immune suppression in inflammation. Crohn's disease in humans is thought to be due to a disruption in mucosal homeostasis so that the host mounts a vigorous Th1 response to the normal flora, similar to an anti-pathogen response. It makes sense in terms of protective immunity to allow pro-inflammatory pathways to predominate until the pathogen is eliminated, or perhaps to dampen anti-inflammatory pathways so that the immune response does not kill the host. Our results here are quite consistent with a cellular corollary of this phenomenon, where IL-21, expressed at increased levels in inflammatory bowel disease, prevents the induction and expression of Treg cell activity, thus allowing ongoing inflammation.

Material and methods

  1. Top of page
  2. Abstract
  3. Introduction
  4. Results
  5. Discussion
  6. Material and methods
  7. Acknowledgements

Mice

BALB/c and SCID mice at 6–8 wk of age were obtained from the animal facility of the University of Rome “Tor Vergata” (Italy). All animal experiments were performed in accordance with the local institutional guidelines. IL-21 knockout mice (B6;129S5-il21tmLex) were purchased from the University of California, Davis, CA, USA and hosted in our animal facility under SPF conditions.

Isolation and culture of primary cells

CD4+CD25 T cells were isolated from murine splenocytes by CD4-MACS® negative selection followed by CD25-MACS® positive selection (Miltenyi Biotech, Bergisch Gladbach, Germany). CD4+CD25 T cell preparations used in all the experiments were at least 97% pure as shown by flow cytometry. Treg cells were induced as previously described 8. In brief, CD4+CD25 T cells were cultured in serum-free medium X-Vivo15 (BioWhittaker, Heidelberg, Germany) in the presence of plate-bound anti-CD3 Ab (1 µg/mL; clone 145–2C11), soluble anti-CD28 Ab (2 µg/mL; clone 37.51) and recombinant TGF-β1 (5 ng/mL; Sigma-Aldrich, Milan, Italy), in the presence or absence of IL-21 (R&D Systems, Minneapolis, MN).

Flow cytometric analysis

Cells were stained for CD4, CD44, CD62L, CD69 (Immunotools, Friesoythe, Germany), CD45RB (BD, Heidelberg, Germany), and FoxP3 (eBioscience, San Diego, CA), according to the manufacturers’ instructions. Cells were analyzed by means of a FASCalibur (BD Bioscience, San Jose, CA).

Transfer-colitis

SCID mice were administered intraperitoneally with freshly isolated CD4+CD25 T cells from BALB/c mice (4 × 105) in the presence or absence of CD4+CD25 T cells (4 × 105) stimulated for 5 days with anti-CD3 and anti-CD28 Ab, recombinant TGF-β1, and/or IL-21. Weight changes were monitored daily. For monitoring of colitis, the Coloview high-resolution mouse video endoscopic system (Karl-Storz, Tuttlingen, Germany) was used as described 24.

Histological analysis of colon cross-sections

Sections were obtained from the colons and stained with hematoxylin and eosin (H&E). The degree of inflammation on microscopic cross-sections of the colon was graded by the same pathologist in a blinded fashion.

Cytokine quantification

TNF-α, IL-6, and IFN-γ levels in the cell culture supernatants were quantified by means of a cytofluorimetry-based ELISA system (Flowcytomix; Bender Medsystems, Vienna, Austria) according to the manufacturer's protocol.

Real-time quantitative PCR

Total RNA was isolated using the peqGOLD Total RNA Kit (Peqlab, Erlangen, Germany). Reverse transcription into complementary DNA (cDNA) was performed with the M-MLV reverse transcriptase (Invitrogen, Karlsruhe, Germany). PCR was performed using a SYBR Green-based PCR using iQ SYBR mix (Bio-Rad, Hercules, CA). Specific primers were designed on the cDNA sequence: FoxP3 sense: 5′-GGT ACAC CCA GGA AAG ACA G-3′; FoxP3 antisense: 5′-ATC CAG GAG ATG ATC TGC TTG-3′; β-actin sense: 5′-AAG ATG ACC CAG ATCATG TTT GAG ACC-3′; β-actin antisense: 5′-agc cag gtc cag acg cag gat-3′; CD3 sense: 5′-GTA TCA CTC TGG GCT TGC TG-3′; CD3 antisense: 5′-TGG GCT CAT AGT CTG GGT TG-3′; TNF-α sense: 5′-ACC CTC ACA CTC AGA TCA TC-3′; TNF-α antisense: 5′-GAG TAG ACA AGG TAC AAC CC-3′; IFN-γ sense: 5′-CAA TAG ACG CTA CAC ACT GC-3′; IFN-γ antisense: 5′-CCA CAT CTA TGC CAC TTG AG-3′; IL-17A sense: 5′-CTC AGA CTA CCT CAA CCG TTC-3′; IL-17A antisense: 5′-TTC AGG ACC AGG ATC CT TGC-3′. IL-21 expression PCR was analyzed using a TaqMan-based assay (Applied Biosystems, Darmstadt, Germany) and the iQ Supermix (Bio-Rad). RORγt expression was analyzed as described 25.

Gene expression was calculated relative to the housekeeping gene β-actin using the ΔΔCt algorithm.

Proliferation assay

CD4+CD25 T cells were labeled with Celltrace CFSE (Invitrogen, Karlsruhe, Germany) according to the manufacturer's instructions. In some experiments, proliferation of CD4CD25 T cells activated in the presence of TGF-β with or without IL-21 was evaluated. In other experiments CFSE-labeled CD4+CD25 T responder cells were co-cultured at different ratios with cells pre-activated for 5 days with TGF-β alone or with the addition of IL-21. Mitomycin-C (Sigma-Aldrich, St. Louis, MO)-treated autologous CD90-negative splenocytes were used as APC. Proliferation of responder cells was evaluated by flow cytometry after 3 days of culture. Quantification of cells undergoing divisions was evaluated by determining the proliferation index obtained with the proliferation module of the ModFit LT Macintosh software.

Statistical analysis

Student's t-test was used to calculate statistical significance in a particular measurement of a continuous variable between groups.

Acknowledgements

  1. Top of page
  2. Abstract
  3. Introduction
  4. Results
  5. Discussion
  6. Material and methods
  7. Acknowledgements

This work received support from the “Fondazione Umberto di Mario”, Rome, the Broad Medical Research Program Foundation (Grant No. IBD-0154R), and Giuliani SpA, Milan, Italy.Conflict of interest: These authors declare that there is no financial or commercial conflicts of interest.

  • 1

    WILEY-VCH

  • 2

    WILEY-VCH

  • 3

    WILEY-VCH

  • 4

    WILEY-VCH

  • 5

    WILEY-VCH

  • 6

    WILEY-VCH

  • 1
    Alderuccio, F., Toh, B. H., Tan, S. S., Gleeson, P. A. and van Driel, I. R., An autoimmune disease with multiple molecular targets abrogated by the transgenic expression of a single autoantigen in the thymus. J. Exp. Med. 1993. 178: 419426.
  • 2
    King, C., Ilic, A., Koelsch, K. and Sarvetnick, N., Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 2004. 117: 265277.
  • 3
    Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. and Toda, M., Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995. 155: 11511164.
  • 4
    Leonard, W. J. and Spolski, R., Interleukin-21: A modulator of lymphoid proliferation, apoptosis and differentiation. Nat. Rev. Immunol. 2005. 5: 688698.
  • 5
    Pesce, J., Kaviratne, M., Ramalingam, T. R., Thompson, R. W., Urban, J. F., Jr., Cheever, A. W., Young, D. A. et al., The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J. Clin. Invest. 2006. 116: 20442055.
  • 6
    Monteleone, G., Monteleone, I., Fina, D., Vavassori, P., Del Vecchio Blanco, G., Caruso, R., Tersigni, R. et al., Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn's disease. Gastroenterology 2005. 128: 687694.
  • 7
    Sakaguchi, S., Ono, M., Setoguchi, R., Yagi, H., Hori, S., Fehervari, Z., Shimizu, J. et al., Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 2006. 212: 827.
  • 8
    Fantini, M. C., Becker, C., Monteleone, G., Pallone, F., Galle, P. R. and Neurath, M. F., Cutting Edge: TGF-beta induces a regulatory phenotype in CD4+CD25 T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 2004. 172: 51495153.
  • 9
    Chen, W., Jin, W., Hardegen, N., Lei, K. J., Li, L., Marinos, N., McGrady, G. and Wahl, S. M., Conversion of peripheral CD4+CD25 naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 2003. 198: 18751886.
  • 10
    Fantini, M. C., Becker, C., Tubbe, I., Nikolaev, A., Lehr, H. A., Galle, P. and Neurath, M. F., Transforming growth factor beta induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis. Gut 2006. 55: 671680.
  • 11
    Dominitzki, S., Fantini, M. C., Neufert, C., Nikolaev, A., Galle, P. R., Scheller, J., Monteleone, G. et al., Cutting Edge: Trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+CD25 T cells. J. Immunol. 2007. 179: 20412045.
  • 12
    Pasare, C. and Medzhitov, R., Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003. 299: 10331036.
  • 13
    Brandt, K., Bulfone-Paus, S., Jenckel, A., Foster, D. C., Paus, R. and Ruckert, R., Interleukin-21 inhibits dendritic cell-mediated T cell activation and induction of contact hypersensitivity in vivo. J. Invest. Dermatol. 2003. 121: 13791382.
  • 14
    Ozaki, K., Spolski, R., Ettinger, R., Kim, H. P., Wang, G., Qi, C. F., Hwu, P. et al., Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J. Immunol. 2004. 173: 53615371.
  • 15
    Mehta, D. S., Wurster, A. L., Whitters, M. J., Young, D. A., Collins, M. and Grusby, M. J., IL-21 induces the apoptosis of resting and activated primary B cells. J. Immunol. 2003. 170: 41114118.
  • 16
    Zeng, R., Spolski, R., Casas, E., Zhu, W., Levy, D. E. and Leonard, W. J., The molecular basis of IL-21-mediated proliferation. Blood 2007. 109: 41354142.
  • 17
    Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B. et al., Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 1993. 90: 770774.
  • 18
    Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D. et al., Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006. 441: 231234.
  • 19
    Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L. and Kuchroo, V. K., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006. 441: 235238.
  • 20
    Korn, T., Bettelli, E., Gao, W., Awasthi, A., Jager, A., Strom, T. B., Oukka, M. and Kuchroo, V. K., IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007. 448: 484487
  • 21
    Nurieva, R., Yang, X. O., Martinez, G., Zhang, Y., Panopoulos, A. D., Ma, L., Schluns, K. et al., Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007. 448: 480483
  • 22
    Herber, D., Brown, T. P., Liang, S., Young, D. A., Collins, M. and Dunussi-Joannopoulos, K., IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression. J. Immunol. 2007. 178: 38223830.
  • 23
    Young, D. A., Hegen, M., Ma, H. L., Whitters, M. J., Albert, L. M., Lowe, L., Senices, M. et al., Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis. Arthritis Rheum. 2007. 56: 11521163.
  • 24
    Becker, C., Fantini, M. C. and Neurath, M. F., High resolution colonoscopy in live mice. Nat. Protoc. 2006. 1: 29002904.
  • 25
    Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J. and Littman, D. R., The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006. 126: 11211133.